(Q46803679)

English

Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287919%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287919%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Meliha C Kapetanovic

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287919%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Saxne T

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287919%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Sjöholm A

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287919%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Truedsson L

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287919%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Jönsson G

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287919%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Geborek P

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287919%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

15 November 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287919%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287919%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

45

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287919%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287919%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

106-111

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287919%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

Predictors of infection in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

Co-morbidity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

Infectious complications of immunosuppressive therapy in patients with rheumatic diseases

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

Infections and biological therapy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

The mortality of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

Infectious complications of biologic treatments of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

Necrotising fasciitis in a patient receiving infliximab for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

Dynamics of penicillin-susceptible clones in invasive pneumococcal disease.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

Effectiveness of pneumococcal polysaccharide vaccine in older adults

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

Vaccines for preventing pneumococcal infection in adults

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

Multistate evaluation of invasive pneumococcal diseases in adults with human immunodeficiency virus infection: serotype and antimicrobial resistance patterns in the United States

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

Measurement and interpretation of pneumococcal IgG levels for clinical management.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

B lymphocyte depletion therapy with rituximab in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI193

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46803679&oldid=1419714277"